Lake Street Advisors Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,008
Closed -$234K 648
2024
Q2
$234K Buy
+1,008
New +$219K 0.01% 503
2024
Q1
Sell
-866
Closed -$224K 658
2023
Q4
$224K Buy
+866
New +$213K 0.01% 517
2021
Q3
Sell
-1,126
Closed -$384K 251
2021
Q2
$384K Buy
1,126
+38
+3% +$11.5K 0.03% 206
2021
Q1
$304K Buy
1,088
+28
+3% +$7.55K 0.02% 235
2020
Q4
$260K Sell
1,060
-102
-9% -$26.3K 0.02% 252
2020
Q3
$330K Buy
1,162
+29
+3% +$8.09K 0.03% 189
2020
Q2
$303K Sell
1,133
-110
-9% -$33.1K 0.03% 200
2020
Q1
$393K Buy
1,243
+346
+39% +$105K 0.05% 133
2019
Q4
$266K Buy
+897
New +$249K 0.03% 205
2019
Q2
Sell
-892
Closed -$211K 232
2019
Q1
$211K Sell
892
-146
-14% -$46K 0.02% 208
2018
Q4
$312K Buy
1,038
+13
+1% +$4.15K 0.04% 133
2018
Q3
$362K Sell
1,025
-390
-28% -$134K 0.04% 127
2018
Q2
$411K Buy
1,415
+86
+6% +$24.2K 0.04% 176
2018
Q1
$364K Sell
1,329
-207
-13% -$64.3K 0.04% 168
2017
Q4
$489K Buy
+1,536
New +$493K 0.06% 147

Other funds holding BIIB

Lake Street Advisors Group's BIIB Position: Q3 2024 in Review

Lake Street Advisors Group sold out of Biogen (BIIB) in Q3 2024, closing a stake of 1,008 shares — an estimated $234K sold.

Lake Street Advisors Group first reported a position in BIIB in Q4 2017 and held it in 15 quarters. The position peaked at $489K in Q4 2017. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Lake Street Advisors Group reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Lake Street Advisors Group sold 1,008 Biogen shares in Q3 2024, an estimated $234K.
  • Lake Street Advisors Group first reported a position in Biogen in Q4 2017 and held it in 15 quarters.
  • Lake Street Advisors Group's Biogen position peaked at $489K in Q4 2017.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Lake Street Advisors Group's 13F filing for Q3 2024, filed 23 Oct 2024.